FDA Commissioner Makary defends agency's decision on Replimune's drug, CNBC reports
U.S. Food and Drug Administration Commissioner Dr. Marty Makary on Tuesday defended the agency's decision to not approve Replimune's drug for advanced skin cancer.
May 05, 2026
DNA from bones on a Revolutionary War battlefield solves the case of 'America's oldest John Doe'
Casino earnings put focus on dealmaking amid slower sector growth
Indonesia central bank says it is monitoring banking liquidity
Transport of dead bodies within Congo risks further Ebola spread, UN agency warns
World Cup beer sales are hopping. Brewers hope the stout demand outlasts the tournament
Soccer-Spain's Sanchez to attend World Cup final alongside Trump amid tensions